Catherine Voegele - Concepedia

Author

Catherine Voegele

Centre international de recherche sur le cancer ORCID

Also Known As

C Voegele, C. Voegele, Catherine Voegele

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Centre international de recherche sur le cancer Centre de Recherche en Cancérologie de Lyon Inserm The University of Melbourne Institut Curie

About

Catherine Voegele is an author at Centre international de recherche sur le cancer specializing in medicine, pathology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	636
2	Cell Biology	4	4	243
3	Engineering	1	1	84
4	Health Sciences	1	1	24
5	Natural Sciences	1	1	24

Catherine Voegele

Publications

Citations

H-Index

Page 1

	Year	Citations
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids Nicolas Alcala, Noémie Leblay, Alice‐Agnes Gabriel, Nature Communications	2019	205
Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer Sean V. Tavtigian, Peter J. Oefner, Davit Babikyan, The American Journal of Human Genetics Breast OncologyCancer RiskCancer EpidemiologyMedicinePathology	2009	189
Rare Mutations in XRCC2 Increase the Risk of Breast Cancer Daniel J. Park, Fabienne Lesueur, Tú Nguyen‐Dumont, The American Journal of Human Genetics Breast OncologyCancer RiskOncogenic AgentMedicinePathology	2012	180
Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus Sonia Garritano, Federica Gemignani, Catherine Voegele, BMC Genetics	2009	147
Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice Daniele Viarisio, Karin Müller‐Decker, Rosita Accardi, PLoS Pathogens Beta Hpv TypesSkin DevelopmentBeta Hpv38Hit-and-run MechanismSkin Cancer	2018	111
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBNcontribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study Francesca Damiola, Maroulio Pertesi, Javier Oliver, Breast Cancer Research	2014	108
No evidence that protein truncating variants in <i>BRIP1</i> are associated with breast cancer risk: implications for gene panel testing Douglas F. Easton, Fabienne Lesueur, Brennan Decker, Journal of Medical Genetics	2016	102
Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study Florence Le Calvez‐Kelm, Fabienne Lesueur, Francesca Damiola, Breast Cancer Research	2011	86
Identification of novel long non-coding RNAs deregulated in hepatocellular carcinoma using RNA-sequencing Davide Degli Esposti, Héctor Hernández‐Vargas, Catherine Voegele, Oncotarget EngineeringPathologyLiver CarcinogenesisTranscriptomics TechnologyLong Non-coding Rnas	2016	84
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study Md. Ismail Hosen, Mahdi Sheikh, Maria I. Zvereva, EBioMedicine	2020	82

Page 1